A 90-day randomised, placebo-controlled clinical trial suggests high-purity Undaria pinnatifida fucoidan could offer a new nutraceutical approach to managing symptoms of benign prostatic hyperplasia (BPH)
Follow Nutraceutical Business Review's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.
You can even combine different feeds with the feed for Nutraceutical Business Review.
Subscribing and unsubscribing is fast, easy and risk free.
The whole service is free of cost.
Nutraceutical Business Review: Nutraceutical Business Review